Print

Declining use of chemotherapy for early-stage breast cancer: examining oncologist recommendations

https://www.facingourrisk.org/XRAY/chemotherapy-early-stage-breast-cancer
Full article: https://doi.org/10.1093/jnci/djx239

A new study shows that chemotherapy use for early-stage, node-positive and node-negative breast cancers declined from 2013 to 2015. It also reports that oncologists’ recommendations are influenced to differing degrees by patient preferences and tumor test results, despite unchanging health care guidelines. (8/21/18)

Questions To Ask Your Health Care Provider

Open Clinical Trials

The following studies are enrolling people with early-stage ER-positive, HER2-negative breast cancer. 

Several other clinical trials for patients with early-stage breast cancer can be found here.

About FORCE

FORCE is a national nonprofit organization, established in 1999. Our mission is to improve the lives of individuals and families affected by adult hereditary cancers.